Form D — Fisher Wallace Laboratories, Inc.
0001787792-25-000005 · filed 2025-06-13
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- $5,000,000
- Total sold
- $0
- Minimum investment
- $2,500
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Fisher Wallace Laboratories, Inc.
- CIK
- 1787792
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 630 FLUSHING AVENUE, BOX 104
BROOKLYN, NY 11206 - Phone
- 917-930-4332
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Kelly Joseph Roman · Executive OfficerBROOKLYN, NY Find on LinkedIn ↗
-
Charles Avery Fisher · DirectorBROOKLYN, NY Find on LinkedIn ↗
View original on SEC EDGAR.